Bisoprolol in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease
Cardioselective Beta-Blockade Using Bisoprolol in Patients With Chronic Heart Failure (CHF) and Coexistent Moderate or Severe Chronic Obstructive Pulmonary Disease (COPD) With or Without Significant Reversibility.
Sponsor: NHS Greater Glasgow and Clyde
Terminated
Inadequate patient recruitment
Other terminated trials from NHS Greater Glasgow and Clyde
Other Chronic Obstructive Pulmonary Disease trials with similar outcome
This PHASE2 trial investigates Chronic Obstructive Pulmonary Disease and Heart Failure and is currently terminated or withdrawn. NHS Greater Glasgow and Clyde leads this study, which shows 5 recorded versions since 2005 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2
First recorded
Mar 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NHS Greater Glasgow and Clyde
For direct contact, visit the study record on ClinicalTrials.gov .